Global Cord Blood Corp
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation… Read more
Global Cord Blood Corp (CORBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2022: 0.000x
Based on the latest financial reports, Global Cord Blood Corp (CORBF) has a cash flow conversion efficiency ratio of 0.000x as of June 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-327.00K) by net assets ($770.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Global Cord Blood Corp - Cash Flow Conversion Efficiency Trend (2007–2022)
This chart illustrates how Global Cord Blood Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Global Cord Blood Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Global Cord Blood Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Stellar V Capital Corp. Unit
NASDAQ:SVCCU
|
0.000x |
|
ECB Bancorp Inc.
NASDAQ:ECBK
|
0.023x |
|
Kitex Garments Limited
NSE:KITEX
|
0.178x |
|
Saha Pathanapibul Public Company Limited
BK:SPC
|
0.016x |
|
Hubtown Limited
NSE:HUBTOWN
|
0.035x |
|
Guangxi Guidong Eletric Power Co Ltd
SHG:600310
|
0.149x |
|
Far East Orchard Ltd
F:O5P
|
0.010x |
|
Hangzhou Huasu Technology Co. Ltd. A
SHE:301157
|
N/A |
Annual Cash Flow Conversion Efficiency for Global Cord Blood Corp (2007–2022)
The table below shows the annual cash flow conversion efficiency of Global Cord Blood Corp from 2007 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-03-31 | $4.88 Billion | $613.61 Million | 0.126x | -12.60% |
| 2021-03-31 | $4.39 Billion | $630.71 Million | 0.144x | -10.44% |
| 2020-03-31 | $3.89 Billion | $624.00 Million | 0.160x | -30.66% |
| 2019-03-31 | $3.42 Billion | $792.12 Million | 0.231x | -11.85% |
| 2018-03-31 | $3.12 Billion | $818.76 Million | 0.263x | -24.14% |
| 2017-03-31 | $1.84 Billion | $637.63 Million | 0.346x | +2.06% |
| 2016-03-31 | $1.71 Billion | $581.00 Million | 0.339x | -12.03% |
| 2015-03-31 | $1.54 Billion | $594.87 Million | 0.385x | +3.56% |
| 2014-03-31 | $1.44 Billion | $536.01 Million | 0.372x | -20.14% |
| 2013-03-31 | $1.24 Billion | $578.63 Million | 0.466x | +62.75% |
| 2012-03-31 | $1.24 Billion | $353.86 Million | 0.286x | +77.32% |
| 2011-03-31 | $1.09 Billion | $176.59 Million | 0.162x | +264.00% |
| 2010-03-31 | $819.61 Million | $36.37 Million | 0.044x | +249.07% |
| 2009-03-31 | $140.28 Million | $-4.18 Million | -0.030x | -44.87% |
| 2008-03-31 | $197.44 Million | $-4.06 Million | -0.021x | -2155.95% |
| 2007-03-31 | $207.69 Million | $-189.15K | -0.001x | -- |